SCHEMBL6165983

SCHEMBL6165983

N#CCCn1nc(-c2ccccc2F)c2c1CCC2=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.44
TSHR P16473 3/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.33
CCKBR P32239 1/20 0.33
GLA P06280 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
BRD4 O60885 1/20 0.32
EP300 Q09472 1/20 0.32
CREBBP Q92793 1/20 0.32
MAOB P27338 2/20 0.32
GAA P10253 2/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA4 P48058 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166822 0.84 HTT (0.44) ALDH1A1KDM4EHRH3BRD4CREBBP
SCHEMBL6165490 0.78 LMNA (0.49) TSHRALDH1A1CYP1A2GLAGAA
SCHEMBL6167036 0.77 RIPK3 (0.39) ALDH1A1BRD4EP300CREBBPMAOB
SCHEMBL6166254 0.77 ALDH1A1 (0.38) TSHRALDH1A1KDM4EBRD4EP300
SCHEMBL6167558 0.77 BRD4 (0.31) BRD4EP300CREBBP
SCHEMBL6164086 0.76 ALDH1A1 (0.36) ALDH1A1KDM4ECYP1A2GLABRD4
SCHEMBL6163581 0.76 CYP1A2 (0.36) TSHRALDH1A1KDM4ECYP1A2GLA
SCHEMBL6165037 0.74 MAOB (0.42) TSHRALDH1A1CYP1A2GLAMAOB
SCHEMBL6166453 0.74 ALDH1A1 (0.39) TSHRALDH1A1CYP1A2BRD4EP300
SCHEMBL6166684 0.70 MAOB (0.33) TSHRKDM4ECYP1A2GLABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed